Minimum Order Quantity 1 Bottle
Packaging Size 28 tablets
Packaging Type Bottles
Dose/Strength (ex. 1 mg or 1 ml) 60 mg
Usage Clinical, Hospital, Personal
Natdac60 Daclatasvir is a drug for the treatment of hepatitis C (HCV). it is approved for Hepatitis C genotype 3 infections.
Daclatasvir inhibits the HCV nonstructural protein NS5A. Recent research suggests that it targets two steps of the viral replication process, enabling rapid decline of HCV RNA.
Daclatasvir has been tested in combination regimens with pegylated interferonand ribavirin, as well as with other direct-acting antiviral agents including asunaprevir and sofosbuvir. It is used with another antiviral medication to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Daclatasvir and sofosbuvir may also be used with another antiviral medication (ribavirin). These medications together reduce the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.
How does daclatasvir work?
Daclatasvir is one of the new direct-acting antiviral drugs that target different steps of the hepatitis C virus (HCV) lifecycle. It is the first-ever approved HCV NS5A replication complex inhibitor, meaning it interferes with a protein the virus uses to reproduce.
Tiredness, headache, nausea, or diarrhea may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.
Buy Daclatasvir (Natdac60) tablet online to treat hepatitis C virus (HCV).